RT Journal Article
T1 GEICAM Guidelines for the Management of Patients with Breast Cancer During the COVID-19 Pandemic in Spain
A1 Martin, Miguel
A1 Guerrero-Zotano, Angel
A1 Montero, Ángel
A1 Jara, Carlos
A1 Filipovich, Elena
A1 Rojo, Federico
A1 Moreno, Fernando
A1 García-Sáenz, Jose Ángel
A1 Alés, Jose Enrique
A1 Chacón, José Ignacio
A1 Cruz, Josefina
A1 Gimenez, Julia
A1 Cruz-Merino, Luis
A1 Algara, Manel
A1 Santisteban, Marta
A1 López Tarruella, Sara
K1 Breast cancer
K1 Pandemic
K1 COVID-19
K1 SARS-CoV-2
K1 Expert recommendations
K1 Neoplasias de la Mama
K1 Pandemia
K1 Coronavirus
K1 Spain
K1 España
AB Breast cancer (BC) is the most common cancer in women in Spain. During the COVID-19 pandemic caused by the SARS-CoV-2 virus, patients with BC still require timely treatment and follow-up; however, hospitals are overwhelmed with infected patients and, if exposed, patients with BC are at higher risk for infection and serious complications if infected. Thus, health care providers need to evaluate each BC treatment and in-hospital visit to minimize pandemic-associated risks while maintaining adequate treatment efficacy. Here we present a set of guidelines regarding available options for BC patient management and treatment by BC subtype in the context of the COVID-19 pandemic. Owing to the lack of evidence about COVID-19 infection, these recommendations are mainly based on expert opinion, medical organizations' and societies' recommendations, and some published evidence. We consider this a useful tool to facilitate medical decision making in this health crisis situation we are facing. IMPLICATIONS FOR PRACTICE: This work presents a set of guidelines regarding available options for breast cancer (BC) patient management and treatment by BC subtype in the context of the COVID-19 pandemic. Owing to the suddenness of this health crisis, specialists have to make decisions with little evidence at hand. Thus, these expert guidelines may be a useful tool to facilitate medical decision making in the context of a worldwide pandemic with no resources to spare.
PB Wiley Periodicals LLC on behalf of AlphaMed Press
SN 1083-7159
YR 2020
FD 2020-07-23
LK http://hdl.handle.net/10668/3269
UL http://hdl.handle.net/10668/3269
LA en
NO Martin M, Guerrero-Zotano A, Montero Á, Jara C, Filipovich E, Rojo F, et al. GEICAM Spanish Breast Cancer Group Steering Committee. GEICAM Guidelines for the Management of Patients with Breast Cancer During the COVID-19 Pandemic in Spain. Oncologist. 2020 Sep;25(9):e1339-e1345.
DS RISalud
RD Apr 20, 2025